Literature DB >> 20831364

Probing the role of point mutations in the cyp51A gene from Aspergillus fumigatus in the model yeast Saccharomyces cerevisiae.

L Alcazar-Fuoli1, E Mellado, M Cuenca-Estrella, D Sanglard.   

Abstract

Azole-resistant strains of Aspergillus fumigatus have been detected and the underlying molecular mechanisms of resistance characterized. Point mutations in the cyp51A gene have been proved to be related to azole resistance in A. fumigatus clinical strains and with different resistance profiles depending on the amino acid change (G54E, G54V, G54R, G54W, M220V, M220K, M220T, M220I). The aim of this work was to express A. fumigatus cyp51A genes in the yeast Saccharomyces cerevisiae in order to better assess the contribution of each independent amino acid substitution to resistance. A tetracycline regulatable system allowing repression of the endogenous essential ERG11 gene was used. The expression of Aspergillus cyp51A alleles could efficiently restore the absence of ERG11 in S. cerevisiae. In general, S. cerevisiae clones expressing. A. fumigatus cyp51A alleles from azole-resistant isolates showed higher MICs to all azoles tested than those expressing alleles from susceptible isolates. The azole susceptibility profiles obtained in S. cerevisiae upon expression of specific cyp51A alleles recapitulated susceptibility profiles observed from their A. fumigatus origins. In conclusion this work supports the concept that characteristics of specific A. fumigatus cyp51A alleles could be investigated in the heterologous host S. cerevisiae.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20831364     DOI: 10.3109/13693786.2010.512926

Source DB:  PubMed          Journal:  Med Mycol        ISSN: 1369-3786            Impact factor:   4.076


  13 in total

1.  SREBP-dependent triazole susceptibility in Aspergillus fumigatus is mediated through direct transcriptional regulation of erg11A (cyp51A).

Authors:  Sara J Blosser; Robert A Cramer
Journal:  Antimicrob Agents Chemother       Date:  2011-10-17       Impact factor: 5.191

2.  Molecular mechanisms of drug resistance in clinical Candida species isolated from Tunisian hospitals.

Authors:  Jamel Eddouzi; Josie E Parker; Luis A Vale-Silva; Alix Coste; Françoise Ischer; Steve Kelly; Mohamed Manai; Dominique Sanglard
Journal:  Antimicrob Agents Chemother       Date:  2013-04-29       Impact factor: 5.191

3.  Impact of Homologous Resistance Mutations from Pathogenic Yeast on Saccharomyces cerevisiae Lanosterol 14α-Demethylase.

Authors:  Alia A Sagatova; Mikhail V Keniya; Joel D A Tyndall; Brian C Monk
Journal:  Antimicrob Agents Chemother       Date:  2018-02-23       Impact factor: 5.191

4.  Antifungal susceptibilities of Aspergillus fumigatus clinical isolates obtained in Nagasaki, Japan.

Authors:  Masato Tashiro; Koichi Izumikawa; Asuka Minematsu; Katsuji Hirano; Naoki Iwanaga; Shotaro Ide; Tomo Mihara; Naoki Hosogaya; Takahiro Takazono; Yoshitomo Morinaga; Shigeki Nakamura; Shintaro Kurihara; Yoshifumi Imamura; Taiga Miyazaki; Tomoya Nishino; Misuzu Tsukamoto; Hiroshi Kakeya; Yoshihiro Yamamoto; Katsunori Yanagihara; Akira Yasuoka; Takayoshi Tashiro; Shigeru Kohno
Journal:  Antimicrob Agents Chemother       Date:  2011-10-24       Impact factor: 5.191

Review 5.  Molecular Tools for the Detection and Deduction of Azole Antifungal Drug Resistance Phenotypes in Aspergillus Species.

Authors:  Anna Dudakova; Birgit Spiess; Marut Tangwattanachuleeporn; Christoph Sasse; Dieter Buchheidt; Michael Weig; Uwe Groß; Oliver Bader
Journal:  Clin Microbiol Rev       Date:  2017-10       Impact factor: 26.132

6.  In Vitro Biochemical Study of CYP51-Mediated Azole Resistance in Aspergillus fumigatus.

Authors:  Andrew G S Warrilow; Josie E Parker; Claire L Price; W David Nes; Steven L Kelly; Diane E Kelly
Journal:  Antimicrob Agents Chemother       Date:  2015-10-12       Impact factor: 5.191

7.  cyp51A-Based mechanisms of Aspergillus fumigatus azole drug resistance present in clinical samples from Germany.

Authors:  Oliver Bader; Michael Weig; Utz Reichard; Raimond Lugert; Martin Kuhns; Martin Christner; Jürgen Held; Silke Peter; Ulrike Schumacher; Dieter Buchheidt; Kathrin Tintelnot; Uwe Groß
Journal:  Antimicrob Agents Chemother       Date:  2013-05-13       Impact factor: 5.191

8.  Azole resistance in Cryptococcus gattii from the Pacific Northwest: Investigation of the role of ERG11.

Authors:  Charles E Gast; Luiz R Basso; Igor Bruzual; Brian Wong
Journal:  Antimicrob Agents Chemother       Date:  2013-08-26       Impact factor: 5.191

Review 9.  The Fungal CYP51s: Their Functions, Structures, Related Drug Resistance, and Inhibitors.

Authors:  Jingxiang Zhang; Liping Li; Quanzhen Lv; Lan Yan; Yan Wang; Yuanying Jiang
Journal:  Front Microbiol       Date:  2019-04-24       Impact factor: 5.640

10.  Ergosterol biosynthesis in Aspergillus fumigatus: its relevance as an antifungal target and role in antifungal drug resistance.

Authors:  Laura Alcazar-Fuoli; Emilia Mellado
Journal:  Front Microbiol       Date:  2013-01-10       Impact factor: 5.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.